The U.S. Food and Drug Administration has cleared the Signos Glucose Monitoring System, an over-the-counter glucose mo ...

The FDA cleared the first glucose monitoring system specifically designed for weight management from Signos, providing a new ...

The FDA approved the first over-the-counter glucose monitoring system designed to help with weight management. Developed by health technology company Signos, the system combines the Stelo by Dexcom ...

The FDA has approved Signos, the first glucose monitoring app using AI to help users lose weight and track real-time food reactions.

Signos Inc. landed U.S. FDA clearance for its over-the-counter glucose monitoring system, which combines Dexcom Inc.'s ...

The Signos Glucose Monitoring System is a mobile device application that receives data from an OTC integrated continuous ...

Signos’s glucose-tracking system uses AI and real-time data to guide healthier habits—no prescription required.

Signos, a purpose-driven metabolic health platform committed to transforming lives through personalized, real-time insights, today announced the launch of Signos Glucose Monitoring System, the first ...

The FDA on Wednesday approved the first-ever glucose monitoring system specifically for weight loss from the startup Signos, establishing a new option for Americans to manage their weight. The Signos ...

The FDA has approved Sisnos’s continuous glucose monitoring (CGM) system for consumer use beyond diabetes management, ...

In a significant development for weight management, the Food and Drug Administration (FDA) announced Wednesday its approval ...

Palo Alto, California-based Signos integrated the Dexcom Stelo OTC continuous glucose monitor (CGM) with an AI-powered ...